Topical conveyance of medications can be accomplished by fusing drug into the gel network for viable conveyance of medications. NSAIDs are non-steroidal medications having superb mitigating and pain-relieving action however NSAIDs produces GIT ulceration, liver and kidney inconvenience particularly if there should be an occurrence of oral organization. Hydrophilic polymers like carbopol-940 and HPMC K100 were used in an attempt to develop topical Emulgel formulations of Naproxen Evaluation tests for visual appearance, pH, consistency, spreadability test, in vitro prescription arrival of, in vivo medication release were performed. In vitro drug release ponders were finished by using Franz spread cell utilizing dialysis layer. The impacts of polymer, oil, surfactant and co surfactant piece on the rate of In vitro and in vivo medication discharge from the gel definitions were inspected through rodent stomach skin mounting on Franz dispersion cell at 37 ± 0.5oC. No conspicuous changes in physicochemical properties of definition were seen after its presentation to quickened states of temperature (40 ± 2oC) and mugginess conditions (75 ± 5% RH). Spreadability, pH and thickness esteems were observed to be marginally changed yet were tantamount with beginning qualities and the strength of the detailing was observed to be unaffected. The gel detailing, (F4) was observed to be reasonable for topical application dependent on in-vitro assessment and in-vivo pervasion thinks about. The optimized formulation, F4 was found to have great patient consistence on account of its simplicity of spreadability and the treatment was observed to be improved as the penetrability of the medication was enhanced.
Cite this article:
Rohini Reddy, Shanthi Priya, Ganesh Akula, Suddagoni Santhosh, Albert Jaswanth. Formulation and Evaluation of Naproxen Emulgel for Topical Delivery. Research Journal of Pharmacy and Technology. 2021; 14(4):1961-5. doi: 10.52711/0974-360X.2021.00347
Rohini Reddy, Shanthi Priya, Ganesh Akula, Suddagoni Santhosh, Albert Jaswanth. Formulation and Evaluation of Naproxen Emulgel for Topical Delivery. Research Journal of Pharmacy and Technology. 2021; 14(4):1961-5. doi: 10.52711/0974-360X.2021.00347 Available on: https://rjptonline.org/AbstractView.aspx?PID=2021-14-4-23
1. Lehman, MD: Microscopy of normal and abnormal skin 1964 US Army chemical research and development laboratories, Special Publication2: 56 10,
2. Vesicles and Skin: From surface to systemic effects (Gamal M. El Maghraby, Department of Pharmaceutical Technology, College of Pharmacy, University of Tanta, Tanta, Egypt, and others) pp.99-120
3. Tortora, G.J. and Derrickson, B. Principles of Anatomy and Physiology, 2006;11th ed. Wiley, Hoboken, NJ, USA.
4. Shaw JE, Urquhart J. Transdermal drug administration - A nuisance becomes an opportunity. BMJ 1981; 283: 875-6.
5. Webster RC, Maibach HI. Cutaneous pharmacokinetics: 10 steps to percutaneous absorption. Drug Metabolism Rev 1983; 14: 169-205.
6. Pathan DN, Shaikh NH, Thube RT, Bhise KS and Polshettiwar SA, Formulation and Evaluation of Floating Drug Delivery System of Cefpodoxime Proxetil, Research J. Pharm. and Tech. 2 (4): Oct.-Dec. 2009, 82-815.
7. Eswaraiah S, Swetha K, Lohita M, P.Jaya Preethi, B.Priyanka, Kiran Kumar Reddy, Emulgel: Review on Novel Approach to Topical Drug Delivery, Asian J. Pharm. Res. 2014; Vol. 4: Issue 1, 04-11.
8. Inayat Bashir Pathan, Mallikarjun Shetty C, Chemical penetration enhancers for transdermal drug delivery systems, Tropical journal of Pharmaceutical Research, 8(2): April 2009; pp. 173-179.
9. K. Moser, K. Kriwet, A. Naik, Y.N.Kalia, R.H. Guy, “Passive skin penetration enhancement and its quantification in vitro”, Eur. J. Pharm. Bio pharmaceutics, Vol. 52, 103-112, 2001.
10. Surber C, et al. Optimization of topical therapy: partitioning of drugs into stratum corneum. Pharma Research. 1990; 7:1320-24.
11. Shah VP, Behl CR, Flynn GL, Higuchi WI, Schaefer H. Principles and criteria in the development and optimization of topical therapeutic products. Pharma Research. 1992; 9:1107-12.
12. Pratiksha V. Shrikhande, Formulation and Evaluation of Polyherbal Topical Anti-Inflammatory Emulgel, Research J. Pharm. and Tech. 6(1): January 2013, 118-122.
13. Govil, S.K., In; Tyle, P., Eds., Drug Delivery: Fundamentals and application, Marcel Dekker, Inc., New York, 1998, 385-406.
14. Chein Y.W. Transdermal drug delivery and delivery system. In, Novel drug delivery system, Vol. 50, Marcel Dekker, Inc., New york, 1992 pp.301-381.
15. Sushil Raut, Vaibhav Uplanchiwar, Santosh Bhadoria, Avinash Gahane, Sunil Kumar Jain, Shrishail Patil, Comparative Evaluation of Zidovudine Loaded Hydrogels and Emulgels, Research J. Pharm. and Tech. 5 (1): Jan. 2012, 41-45.
16. Wiechers J. Use of chemical penetration enhancers in transdermal drug delivery-possibilities and difficulties. ActaPharma. 1992 : 4: 123.
17. Jain NK. Advances in controlled and novel drug delivery, 1st Ed., CBS publishers and distributors, New Delhi, 2001; 108-110.
18. Wiechers J. Use of chemical penetration enhancers in transdermal drug delivery-possibilities and difficulties. Acta pharm. 1992; 4: 123
19. Barrie C. Finnin, Timothy M. Morgan. Transdermal penetration enhancers: Applications, limitations, and potential. Journal of Pharmaceutical Sciences, 1998, Volume 88, Issue 10: 955–958
20. A.M. Lowman, N.A. Peppas, Solute transport analysis in pH-responsive, complexing hydrogels of poly (methacrylic acid-ethyleneglycol), J. Biomaterial. Science and, Polymers Ed. 10 1999: 999–1009.
21. C.S. Brazel, N.A. Peppas, Modeling of drug release from sellable polymers, Eur. J. Pharm. Biopharm. 49 2000: 47–58.